Evidence from preclinical experiments that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) could be used as a therapeutic target to kill bladder cancer cells, help prevent metastasis and even be used to non-invasively diagnose the disease and monitor its progression. The evidence was provided by scientists from Virginia Commonwealth University Massey Cancer Center. The study, published in the journal iClinical Cancer Research/i, ...Saturday, 27 July 2013
Study: Novel Gene Target Shows Promise for Bladder Cancer Detection and Treatment
Evidence from preclinical experiments that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) could be used as a therapeutic target to kill bladder cancer cells, help prevent metastasis and even be used to non-invasively diagnose the disease and monitor its progression. The evidence was provided by scientists from Virginia Commonwealth University Massey Cancer Center. The study, published in the journal iClinical Cancer Research/i, ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment